Table 1.
Demographics and clinical characteristics of all patients pre and post intervention.
Fig 1.
Consort diagram inclusion and exclusions.
CA-AKI–Community-acquired AKI, HA-AKI–Hospital-acquired AKI, SCr–serum Creatinine.
Fig 2.
Summary of intervention. At the control site no alerts were generated. RED boxes = AKI (community or hospital-acquired), AMBER = APS ≥5 points–cut-off for flagging patient at risk of AKI, GREEN box–all other patients (APS <5 points). HA-AKI–Hospital-acquired AKI, PAS–Patient administration system, SCr–serum creatinine. Patientrack AKI ALERT* ^AKI Prediction Score (APS)–clinical prediction rule.
Fig 3.
Top left (A): Patient tile indicating presence and stage of AKI, baseline SCr and care bundle task status; top right (B): electronic observation chart with AKI status (present or at risk) in top right of screen with link to SCr results; bottom left (C): graph of SCr; bottom right (D): AKI care bundle. SCr–serum creatinine. Note that details for illustration only and are not of a real patient.
Table 2.
Incident HA-AKI pre and post intervention unadjusted and difference-in-differences analysis.
Fig 4.
In-patient mortality in cases who developed HA-AKI before and after the intervention.
HA-AKI–hospital-acquired AKI, OR–odds ratio (95% CI).
Table 3.
HA-AKI cases—pre and post intervention outcomes with adjusted difference-in-differences.
Table 4.
In-patient mortality in cases with CA-AKI and in those flagged at high-risk on admission by the CPR.
Fig 5.
The learning health system–AKI as a case study.
AI–artificial intelligence.